Newsroom

Top highlights include: Government to launch $300M Azlheimer's research database, new COVID variant XBB.1.16 spotted in 18 US states, and novel treatment shows promise against rare cancer in kids.

Today's Highlights Include: US FDA seeks to allow salt substitutes in everyday foods, radioactive water leaks at Minn. nuclear plant for 2nd time, and pushback grows over mental health impacts of social media.

In a post on Mayo Clinic’s News Network, Mayo Clinic’s director of Clinical Virology, Matthew Binnicker, Ph.D., explains the concern over a potential human-to-human outbreak of avian influenza and what’s being done at Mayo Clinic and elsewhere to mitigate that risk.

Today's Highlights Include: CDC adds COVID vaccine to routine immunization schedule for kids and adults, Governments target medical debt with COVID relief funds and Minnesota being the 1st state to screen all newborns for serious viral infection.

Today's Highlights Include: USDA proposes new nutrition standards for school meals, virtual care system designed for COVID-19 grows into a multiuse digital health tool, and Mayo Clinic explores use of artificial intelligence. Is It Hype Or Help?

Are you planning to attend Medlab Middle East 2023? If so, make an appointment to stop by Mayo Clinic Laboratories’ booth Z3.A30 to learn more about our comprehensive menu of advanced diagnostic testing.

Topic highlights include: FDA considers major shift in COVID vaccine strategy, DNA from blood samples could help early cancer detection, Wisconsin researchers say, CDC informs staff of reorganization after pandemic criticisms

The New England Journal of Medicine recently published new findings on periprosthetic joint infection by Dr. Robin Patel.

Topic highlights include: Phoenix Children’s opens specialty clinic at Avondale campus, Moderna says RSV vaccine is effective in older adults, WHO questions severity of XBB.1.5 COVID subvariant as U.S. cases rise

Education on this topic decreases misdiagnosis and the possibility of misinterpreting the comments provided by the reporting laboratories.

Topic highlights include: With attention to mpox fading, health officials fear infections will go undetected and unreported, As COVID surges in China, US begins testing more travelers, FDA approves Alzheimer's drug that appears to modestly slow disease

Mayo Clinic Laboratories is excited to announce our participation in Medlab Middle East 2023, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 6–9, 2023.

Topic highlights include: Public health agencies try to restore trust as they fight misinformation, Telehealth brings expert sexual assault exams to rural patients, FDA decision on experimental Alzheimer’s drug expected this week.